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ABSTRACT
Allen, Hilary Kaye. M.S., Microbiology and Immunology, Wright State University, 2012.
The Effects of Enteropathogenic and Commensal Escherichia coli on Tight Junction
Permeability.

The intestinal mucosa maintains a barrier between materials from the external
environment and the internal environment of the host. Disruption of the gut wall
integrity is involved in the development of various intestinal diseases, such as Irritable
Bowel Syndrome (IBS) and Crohn’s disease. The intestinal mucosa is lined with
epithelial cells that are connected by tight junctions, the intercellular junctions that form a
selectively permeable barrier between paracellular pathways. Enteric pathogens, such as
enteropathogenic Escherichia coli (EPEC), can disrupt the tight junctions of epithelial
cells by altering the cellular cytoskeleton or by directly affecting tight junction proteins.
Commensal Escherichia coli can also modify intestinal epithelial barrier function,
however, the role of commensal E. coli in tight junction permeability is not fully
understood. Here, the effects of enteropathogenic and commensal E. coli on intestinal
epithelial barrier integrity, with a focus on tight junction permeability, will be discussed.
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I. INTRODUCTION
The intestinal mucosa maintains a barrier between materials from the external
environment and the internal environment of the host (1). Disruption of the gut wall
integrity is involved in the development of various intestinal diseases, such as Irritable
Bowel Syndrome (IBS) and Crohn’s disease and plays a major role in the onset of sepsis
and multiple organ failure (2). The defense mechanisms of the intestinal epithelial barrier
consist of a physical and immunological component (2). The physical barrier is lined
with epithelial cells that are connected by tight junctions, which will be the main focus of
discussion (2).
Tight junctions are adhesion structures that form a selectively permeable barrier
between paracellular pathways (2). Enteric pathogens disrupt epithelial barrier function
through alteration of tight junctions via various mechanisms, for example, through
modification of the cellular cytoskeleton or redistribution of tight junction proteins (3).
The disruption of tight junctions by enteric pathogens is generally measured by a
reduction in transepithelial resistance (TER) or an increase in paracellular flux of
macromolecules (3).
Many enteropathogenic bacteria have been implicated in the disruption of tight
junctions including enteropathogenic E. coli (EPEC), enterohemorrhagic E. coli (EHEC),
Clositridium difficile, Clostridium perfringens, Helicobacter pylori, Campylobacter
jejuni, Campylobacter concisus, and Salmonella typhimurium (3). Several of these
bacteria disrupt tight junctions through disorganization of specific tight junction proteins,
including zonula occludens, occludin, and claudin (4). The mechanisms by which EPEC
1

affect tight junction barrier function are discussed here.
Enteropathogenic Escherichia coli (EPEC) are gram-negative bacteria that cause
diarrhea and significant infant mortality in developing countries (5). EPEC are
characterized by the attaching and effacing (A/E) lesions observed during infection
(Figure 1). EPEC intimately attach to pedestal-like projections of the apical enterocyte
membrane, followed by destruction of microvilli (Figure 1). The A/E lesions are believed
to adhere EPEC to the cell surface, as EPEC remains extracellular during pathogenesis
(5).

Figure 1. Electron micrograph of EPEC infected human intestinal mucosa. Adapted from
Chen et al. 2005
EPEC secretes various proteins during infection via the type three secretion
system (TTSS) (Figure 2). The TTSS is utilized by a variety of enteric pathogens and
2

acts as a syringe injecting effector proteins into host cells (Figure 3). In contrast to
commensal E. coli, EPEC contains a 35.6 kb pathogenicity island known as the locus of
enterocyte effacement (LEE) that is also involved in EPEC virulence (5).

Figure 2. Type III protein translocation in EPEC. Adapted from Chen et al. 2005

3

Figure 3. A. Effector protein filaments (black arrows) forming a bridge between bacteria
and epithelial cells during early stages of A/E lesion formation. B. Effector protein
filaments (black arrows) connecting EPEC bacteria to the plasma membrane enabling
injection of translocated effector proteins. Adapted from Chen et al. 2005.

The adult human gut is home to approximately

bacterial cells, with each host

possessing a unique composition of bacterial species (6). The gastrointestinal tract is
covered by mucus that is secreted by goblet cells (7). The small intestine has only one
layer of mucus, compared to the two layers in the stomach and colon (7). The production
of mucins provides an important energy source for commensal bacteria within the gut (7).
The commensal intestinal microbiota plays a key role in promoting a healthy
environment within the host, including a healthy intestinal pH, immune homeostasis, and
metabolism (6). Commensal bacteria can also prevent the colonization of pathogenic
bacteria by competing for space (8).
An important part of the gut immunity is distinguishing between commensal and
4

pathogenic bacteria (9). This is extremely important in the intestine, where the immune
system is continually challenged with microorganisms without inducing an inflammatory
response (9). A key component of distinguishing non-pathogenic vs. pathogenic
organisms in the host is intestinal mononuclear phagocytes (iMPs) (9). The iMPs that
generally reside in the intestinal lamina propria (macrophages and dendritic cells) are
hyporesponsive to bacterial stimulation, which may account for a lack of inflammatory
response to normal gut microbiota (9).
Commensal Escherichia coli, a rod-shaped, gram-negative facultative anaerobe,
are an important component of the gut microflora (6). Changes in concentration of
commensal E. coli have been implicated in various intestinal diseases such as Crohn’s
disease (6). For example, Packey et al. described several ways in which commensal
enteric bacteria induce and maintain chronic inflammation in the intestines associated
with inflammatory bowel disease (IBD): abnormal microbial composition, defective host
containment of commensal bacteria, and defective host immunoregulation (6).
Modulations of the gut microbiota have also been shown to increase or decrease
epithelial barrier integrity by altering the expression of tight junction proteins (8). For
example, modulating the gut microbiota with a dietary supplement of a prebiotic resulted
in increased expression of the tight junction proteins ZO-1 and occludin, thereby
increasing intestinal epithelial barrier integrity (8).
Both enteropathogenic E. coli and commensal E. coli have been shown to modify
tight junction permeability. EPEC-induced disruption of tight junctions has been studied
extensively in vitro and in vivo, with a general focus on alteration of tight junction
5

proteins (10). For example, Muza-Moons et al. demonstrated the interactions between
the tight junction proteins occludin and claudin with ZO-1 are lost in response to EPEC
infection (10). In contrast, a great deal less is known about the role of commensal E. coli
in tight junction permeability. Here, the effects of enteropathogenic and commensal E.
coli on intestinal epithelial barrier integrity will be discussed, with a focus on tight
junction permeability.
II. BACKGROUND
1. Intestinal Epithelial Cells
Polarized epithelial cells are located between the lumen and the deep cell layers of
the organs (Figure 4). The epithelial cells and the lamina propria (a constituent of
membrane linings composed of a thin layer of connective tissue) make up the intestinal
mucosa (1). Epithelial stem cells develop into four major types of epithelial cells;
enterocytes, goblet cells, enteroendocrine cells, and Paneth cells (1). The enterocytes of
the intestinal epithelium will be the main focus of discussion here.
Intestinal epithelial cells display distinct apices and bases, where they anchor into
the extracellular matrix (11). Neighboring cells attach to one another laterally through
intercellular junctions (11). The apical junction complex, consisting of the tight junction,
adherens junction, and desmosome, is located at the most apical lateral plasma membrane
(11).
The tight junctions and adherens junctions attach to actin filaments through
cytoplasmic adaptor proteins and are involved in many signaling pathways (11). The
6

components of the apical junction complex contain various transmembrane proteins,
cytoskeletal elements, and cytoplasmic scaffolding proteins, all of which work together to
prevent luminal material from entering tissues (11).

Figure 4. Representation of junctions in polarized epithelial cells. Adapted from
Guttman et al. 2009.

2. Tight Junction Structure and Function
Tight junctions are the most apically located of the intercellular junctions that
7

function as the primary barrier to the diffusion of solutes through the paracellular
pathway (12). Tight junctions are found in epithelial cell types, including endothelial
cells, mesothelial cells, and other types of cells such as Schwann cells, oligodendrocytes,
and Sertoli cells (12, 13). Observation of tight junctions by transmission electron
microscopy reveals a series of membrane fusions between adjacent cells, often referred to
as “kisses” (13).
When viewing tight junctions with freeze-fracture electron microscopy, the
“kisses” appear as networks of intramembranous particle fibrils, or tight junction strands
(Figure 5). As tight junctions are a semipermeable barrier to ion, solute, and water
transport, they are involved in the coordination of many signaling and trafficking
molecules (13). The signaling pathways include regulation of cellular differentiation,
proliferation, and polarity, all of which are crucial in establishing tissue compartments
and homeostasis within the body (13).

Figure 5. Freeze fracture image of tight junctions in mouse intestinal epithelial cells. The
tight junctions appear as fibrils, or tight junction strands, as indicated by the arrow.
Adapted from Furuse et al. 2012.
8

As expected, disruption of tight junctions is implicated in many intestinal
diseases, such as inflammatory bowel disease (IBD) (13). Furthermore, previous studies
have demonstrated the various transmembrane proteins of tight junctions are altered and
translocated during intestinal diseases and bacterial infections (13). For example, the
interferon-gamma (IFN-γ) induced internalization of the tight junction proteins claudin-1
and -4 in T84 cells may contribute to barrier dysfunction in IBD (13).
3. Tight Junction Proteins
The first identified protein of tight junctions, occludin, is a 60-kDa protein
containing two extracellular loops (See figure 6 for an overview of tight junction
proteins) (13). The C-terminal domain of the long loop of occludin is abundant in serine,
threonine, and tyrosine residues that are phosphorylated by different protein kinases (13).
The C-terminal region also binds directly to ZO-1, a junctional adhesion molecule that
associates with the actin cytoskeleton (Figure 6).

Figure 6. The molecular components of tight junctions. Adapted from Chiba et al., 2008.
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Occludin was originally believed to play a role in barrier function; however, a
previous study showed occludin-deficient embryonic stem cells developed into epithelial
cells with functioning tight junctions (13). Other studies have shown occludin may play
a part in tight junction formation and cell adhesion, for example, in MDCK cells occludin
induced an increase in TER (14). As the function of occludin is still not yet fully
understood, extensive analysis of the protein will be necessary in future studies.
The next important member of the tight junction family is claudin. Claudins are
generally 18- to -27kDa proteins and contain a short N-terminus, two extracellular loops,
and a C-terminal domain (13). The claudin family consists of 24 members, and is
considered the “backbone” of the tight junction (13). Claudins can also directly bind to
PDZ domain-possessing proteins such as ZO-1, ZO-2, and ZO-3 (Figure 7).

Figure 7. A membrane-spanning model of the Claudin protein. The PDZ domain binding
motif is located at the carboxyl terminus. Adapted from Future et al. 2010.
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Claudin proteins are expressed in most types of epithelial cells and are considered
a major determinant of tight junction barrier functions, such as paracellular charge and
size selectivity (13). In claudin proteins, unlike occludin, paracellular pores (channels)
are created for ions between adjacent cells, a process mediated within the first
extracellular loop (13).
Altered claudin expression and distribution has been implicated in a number of
human diseases. For example, the internalization of claudin-1 and -4 is believed to be
involved in the barrier dysfunction in IBD in the human intestinal epithelial T84 cells
(13). Although, a limitation within the study was cell line specificity, as IBD is a
systemic disease. Studies have also shown an increased expression of claudin proteins in
various types of cancers (13).
The last member of the tight junction family discussed here is the zonula
occludens (ZO). Within tight junctions, PDZ domain-containing cytoplasmic proteins
interact with integral membrane proteins to form cytoplasmic plaques (12). The plaques
work as scaffolds to recruit other proteins and the actin cytoskeleton to the surface of
tight junctions (12). The proteins ZO-1, ZO-2, and ZO-3 are part of these cytoplasmic
plaques (12).
As mentioned before, the domains of the ZO proteins directly bind to the Cterminus of claudins (12). ZO-1 is also capable of binding to occludin and junctional
adhesion molecule-A (JAM-A), an additional tight junction-associated integral
membrane protein) (12). The ZO proteins can also interact with actin filaments (12).
ZO-1 and ZO-2 are believed to be absolutely necessary for tight junction
11

formation in epithelial cells (12). For example, disruption of the ZO-1 gene and
depletion of the ZO-2 protein led to deficient tight junction formation in mouse epithelial
cells (12). ZO-1 is also believed to induce claudin polymerization into tight junction
strands (12).
III. THE EFFECTS OF COMMENSAL ESCHERICHIA COLI ON TIGHT
JUNCTION PERMEABILITY
1. Commensal Bacteria as a Threat to the Epithelium Under Metabolic Stress
Metabolic stress may play a pivotal role in the pathophysiology of gut diseases
such as inflammatory bowel disease (IBD) (15). Currently, there is no cure for IBD, and
most therapies are not ideal given the possible side effects (13). It is hypothesized that
IBD is caused by an inappropriate immune response to the normal flora of the gut, and
different stressors exacerbate these effects on epithelial permeability (15).
Nazli et al. used the chemical stressor dinitrophenol (DNP, an uncoupler of
oxidative phosphorylation) to investigate the effects of commensal E. coli on epithelial
permeability during metabolic stress in rats (15). The authors hypothesized that when
enteric epithelia are under metabolic stress, they will “perceive” normal gut bacteria as a
threat, leading to a loss of barrier function, increased translocation of bacteria into the
mucosa, and increased chemokine synthesis (15).
The experimental methods consisted of injecting DNP into the ileal lumen of rats
(15). Segments of the ileum were removed 6 or 24 hours later and portions of the tissue
were fixed and stained with hematoxylin and eosin (H&E) (15). Portions of the tissue
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were then mounted in Ussing chambers (an instrument that measures short-circuit current
as an indicator of net ion transport across an epithelium) in order to measure barrier
function (15).
The results of the study showed DNP treatment induced an increase in epithelial
permeability, as measured by ion conductance and transepithelial flux (15). There was
also increased immune cell traffic to the gut in the 6 to 24-hour period, as indicated by an
increased amount of immune cells, including mononuclear cells and granulocytes, in the
mucosa (15). There were approximately 130 mononuclear cells/mm² with DNP at 6
hours after treatment compared to approximately 70 cells/mm² in untreated controls (15)
The cell lines used for the in vitro cell culture studies were human colon-derived
crypt-like T84 and HT-29 epithelial cell lines (15). Non-pathogenic E. coli strains
HB101 and C25 were cultured and added to, along with DNP, filter-grown monolayers
(15). The control systems consisted of time-matched naïve monolayers, DNP only, and E.
coli HB101 or C25 only (15). Enteropathogenic E. coli was used as a positive control for
bacterial disruption of epithelial barrier function (15).
After cell monolayers were exposed to DNP and nonpathogenic E. coli HB101, a
significant increase in epithelial permeability (represented as a decrease in TER) and an
increase in transepithelial flux occurred (15). In the control group, TER (presented as a
percent of pretreatment values) was approximately 100% and in the DNP+HB101 treated
monolayers TER was approximately 60% after 24 hours of exposure (13). Exposure of
the monolayers to DNP and nonpathogenic E. coli alone did not affect TER (15).
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The results were slightly different when E. coli strain C25 was administered, as
the strain induced a decrease in TER without the addition of DNP (13). When combined
with DNP, TER decreased even further (15). The results indicate E. coli C25 as a
possible low-grade-pathogen and stressed epithelia are more sensitive to this strain of E.
coli (15).
Nazli et al. also demonstrated that the increase in epithelial permeability induced
by DNP + E. coli HB101 was due to the impact of DNP on the epithelium and not a
result of a bacteria-derived product (15). The combination of DNP + E. coli HB101 also
resulted in significant bacterial translocation across filter-grown epithelial monolayers
(15). The increase in bacterial translocation was not observed when monolayers were
treated with E. coli HB101 only (15).
Together, the experiments by Nazli et al. demonstrated a strain of commensal E.
coli, when coupled with a chemical stressor, can disrupt epithelial barrier function in
vitro (15). Previous studies have shown altered energy metabolism in gut tissues from
patients with IBD, for example, decreased ATP levels were found in inflamed tissue
excised from IBD patients (15). Epithelial barrier maintenance is dependent on
regulation of the tight junctions, which is an energy-dependent process (15). Therefore, it
is of interest to investigate alterations in epithelial barrier function during metabolic stress
in association with the normal gut flora.
Nazli et al. demonstrated a link between commensal bacteria and an alteration in
epithelial barrier function during metabolic stress (15). The epithelium may perceive the
normal gut flora as a threat during stress (15). This link may be implicated during certain
14

inflammatory bowel diseases such as Crohn’s disease, and ulcerative colitis (15). Future
studies should include a more detailed investigation into what proteins of the tight
junctions are altered, by measuring the expression levels of occludin, claudin, or ZO-1.
Nazli et al. analyzed the specific tight junction proteins that were altered as a
result of a DNP+E. coli HB101 induced decrease in paracellular permeability (16). The
study included a more structural assessment of the effects of nonpathogenic E. coli and
DNP on tight junction protein expression, transepithelial resistance (TER), and bacterial
translocation (16). Nazli et al. demonstrated enteric epithelial cells experiencing stress,
or an altered energy balance, are capable of endocytosing commensal bacteria that can
subsequently cross the epithelial layer (16).
The experimental methods involved treating confluent filter-grown monolayers of
the human colonic T84 epithelial cell line with 0.1 mM DNP and nonpathogenic E. coli
HB101 with or without pretreatment with pharmacological agents (16). Transepithelial
resistance was measured after 5 and 7 days of culture with a voltmeter and matched
electrodes (16). Flux assays were performed by adding horseradish peroxidase (HRP) to
the apical side of the filter-grown T84 monolayers (16). Intact HRP was determined by
kinetic enzymatic assay as the amount of HRP recovered compared to the initial
concentration (16).
For the analysis of tight junction proteins, protein concentrations were measured
using a microplate assay. Next, SDS loading buffer was added to each sample and
separated proteins were electroblotted (16). The blots were washed and incubated with
15

the following tight junction proteins: ZO-1, occludin, claudin-1, claudin-2, and claudin-4
(16).
The four treatment groups used in the study were as follows: naïve controls, cells
receiving pharmacological agent treatment only, DNP + E. coli HB101 (the positive
control), and DNP + E. coli HB101 + pharmacological agent (the test condition) (16). As
previous studies have shown microtubule architecture to play a role in paracellular
permeability, it was also important to investigate whether the DNP and E. coli HB101induced decrease in TER was diminished by microtubule or microfilament stabilization
(16). Nazli et al. demonstrated that cytochalasin D (a depolymerizing drug) did not
prevent a drop in TER caused by a 24h culture with DNP + E. coli HB101 (16).
As a reduction in TER is associated with altered tight junction structure and more
“open” tight junctions, Nazli et al. investigated the effects of DNP and E. coli HB101 on
specific tight junction proteins (16). The results showed DNP and E. coli HB101 alone
affected the expression of actin, occludin, and ZO-1 (a decrease in expression compared
to the uninfected control), although the effects were not statistically significant (16).
However, in T84 cells treated previously with DNP + E. coli HB101, the
expression of actin, occludin, and ZO-1 were all significantly reduced (16). There were
no changes detected in the protein levels of claudin-1, claudin-2, and claudin-4 (16).
This may be due to the fact that claudin proteins are believed to be more adhesive than
occludin proteins, and therefore it is more difficult to alter expression levels during
epithelial disruption (11, 12, and 16).
16

Next, Nazli et al. investigated whether blocking endocytosis would reduce
bacterial internalization and translocation (16). Using methyl-β-cyclodextrin (MβCD)
and phenylarside oxide (PAO), membrane cholesterol level and clathrin-coated pit
formation reducing agents, respectively, there was no statistically significant abolishment
of the DNP+E.coli HB101-induced drop in TER (16). However, cotreatment with MβCD
or PAO inhibited bacterial internalization (16). MβCD reduced bacterial internalization
by 85% compared to T84 cells treated with DNP+E. coli only, and PAO reduced bacterial
internalization by approximately 45% (16).
Overall, the results of the study contribute to previous indications that
nonpathogenic bacteria can increase gut paracellular permeability (16). Commensal
bacteria may possess disease-promoting capabilities, especially during times of intestinal
stress, such as reduced intestinal epithelial barrier integrity (16). A reduction in TER is
indicative of altered tight junction structure, which is highlighted by the immunoblot
analysis that showed a decrease in expression of various tight junction proteins in
DNP+E. coli HB101 treated cells (16).
It is also important to note that DNP or E. coli HB101 alone caused a lesser
degree of reduction in expression level of the same tight junction proteins (16).
Therefore, in order for commensal bacteria to induce a decrease in epithelial barrier
function, an additional perturbation of the enterocyte may be necessary (16).
Pharmacological agents used to block rearrangements of the enterocyte
cytoskeleton or endocytosis also did not abrogate the DNP + E. coli HB101-induced drop
17

in TER (16). These observations may indicate a direct effect on tight junction proteins
and not cytoskeletal interference (16). In contrast, interference with the cytoskeleton has
been previously described during EPEC infection (16).
In conclusion, an alteration in epithelial energy balance (caused by DNP) may
lead to the internalization of nonpathogenic bacteria in association with an increase in
epithelial permeability (16). Next, it will be crucial to determine the signaling pathways
involved in the alteration of the tight junction protein expression (16). Future studies of
this nature will be important for providing evidence of commensal bacteria triggering and
exacerbating chronic intestinal inflammatory diseases (16).
As commensal bacteria do not usually invade enterocytes, the underlying
mechanisms by which commensal bacteria cross the epithelial barrier under conditions of
stress and various inflammatory disorders is still not fully understood (17). Previous
studies have implicated the release of proinflammatory cytokines, such as interferon
gamma (IFN-γ) as contributors to gut barrier impairment (17).
Clark et al. investigated the mechanisms of IFN-γ mediated bacterial translocation
across human colonic T84 monolayers (17). The proposed mechanism is commensal
bacteria enter the body through “leaky” tight junctions, which can potentially lead to the
development of disorders such as inflammatory bowel disease and sepsis (17). Clark et
al. investigated the role of nonpathogenic Escherichia coli strain C25 in translocation
across epithelial monolayers exposed to IFN-γ (17). Clark et al. showed IFN-γ-mediated
translocation of E. coli C25 is a transcellular process involving lipid rafts, as opposed to
an alteration in paracellular permeability and tight junction disruption (17).
18

The experimental methods included E. coli C25 translocation across Caco-2 and
T84 cell colonic epithelial monolayers, which were exposed to varying concentrations of
IFN-γ for 48 hours (17). The TER of the monolayers was measured at the end of the time
period and tight junction protein expression was analyzed with immunoblotting and after
band visualization, stained with Coomassie blue to confirm equal protein loading in each
well (17). The tight junction proteins analyzed in the study were occludin, ZO-1, and
claudin-1 (17).
The methods of immunofluorescence included cells cultured on Transwell
supports and exposed to medium alone or IFN-γ and then visualized by confocal laser
scanning microscopy (17). Addition of IFN-γ to the T84 colonic cells resulted in
increased paracellular permeability, measured by a loss of TER and increased
permeability to the paracellular probe LY (17). The permeability effects were dose
dependent, with significant changes at 10 IU/mL IFN-γ (17).
In addition, treatment with IFN-γ resulted in a dramatic increase in translocation
of E. coli C25 from the apical to the basolateral compartment (17). The effects of IFN-γ
on E.coli C25 translocation across colonic epithelial monolayers were assessed with
Transwell culture inserts that were exposed to varying concentrations of IFN-γ (0100IU/mL) for 48 hours (17). The translocation of E. coli C25 occurred at a much lower
IFN-γ concentration (1 IU/mL) than what was necessary for a permeability increase (17).
The immunoblot analysis of tight junction proteins demonstrated an uncoupling of
IFN-γ-mediated changes in bacterial paracellular permeability and translocation (17).
Occludin expression decreased in detergent-insoluble and soluble membrane fractions
19

from T84 cells after exposure to 100 IU/mL IFN-γ (Figure 4). The same concentration of
IFN-γ lead to an increase in claudin-1 expression compared to untreated controls (Figure
8). However, at 1 IU/mL IFN-γ, the same concentration that E. coli C25 translocation
was highly stimulated, both tight junction proteins occludin and claudin did not show any
change in expression or distribution compared to the untreated control (Figure 8).

Figure 8. The effects of IFN-γ on tight junction proteins occludin and claudin-1 in T84
cells. Protein expression was determined in detergent-soluble (S) and detergent-insoluble
(I) membrane fractions. Adapted from Clark et al. 2005

Similar results were obtained when using Caco-2 cells rather than T84 cells (17).
A concentration of 100 IU/mL IFN-γ had no effect on the expression or rearrangement of
occludin or claudin-1 compared to control monolayers (17). However, translocation of E.
coli C25 occurred at IFN-γ concentrations greater than or equal to 10 IU/mL in Caco-2
monolayers (17) Overall, the results indicated IFN-γ may induce the translocation of
nonpathogenic E. coli across an unaltered epithelium without disrupting tight junction
integrity, in terms of occludin and claudin-1 expression levels (17).
20

Lipid rafts may allow a portal of entry for bacteria into eukaryotic cells (17).
Therefore, Clark et al. investigated whether IFN-γ-mediated translocation of E. coli C25
in Caco-2 cells occurred via raft-dependent pathways (17). The experiment involved the
use of filipin and methyl-β-cyclodextrin (MCD), agents that sequester membrane
cholesterol and disrupt raft-dependent processes (17). Pre-treatment of Caco-2 cells with
filipin and MCD dose-dependently inhibited IFN-γ-mediated translocation of E. coli C25
(17).
Clark et al. further investigated the lipid rafts as a means of bacterial translocation
with the assessment of the ganglioside GM1, a marker of raft formation that localizes to
lipid rafts (17). The Caco-2 cells were incubated with or without 100 IU/mL of IFN-γ
labeled with cholera toxin, which specifically binds to GM1 (17). GM1 levels markedly
increased after incubation with IFN-γ compared to untreated controls (17).
In conclusion, the results of the study challenge the concept that tight junction
disruption is necessary for IFN-γ-mediated translocation of nonpathogenic bacteria (17).
It is believed that a loss of tight junction integrity leads to an increase in paracellular
permeability, which then allows bacterial translocation followed by a prolonged
inflammatory response (17). Clark et al provided contradictory evidence to the previous
hypothesis, by demonstrating IFN-γ-exposed T84 and Caco-2 monolayers promote
commensal E. coli C25 translocation, in the absence of paracellular permeability and
tight junction alterations (17). This may be explained by the ability of IFN-γ to
upregulate immune accessory molecules, such as integrins, that are associated with
attachment and internalization of commensal bacteria (17).
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Clark et al. also demonstrated a novel mechanism by which enteric bacteria
invade the epithelium: lipid rafts (17). These rafts, or membrane microdomains, contain
cholesterol and glycosphingolipids and are involved in many cellular processes (17).
Clark et al. showed IFN-γ induced cellular changes allow E. coli C25 to use lipid rafts as
a means of internalization (17). This process may also enhance the survival of E. coli
C25, as phagosomes derived from lipid rafts can avoid degradation by the host cell
lysosomes (17)
Overall, the findings of the study suggest commensal bacteria may use a lipid raftmediated pathway, under inflammatory stress, to cross the epithelial barrier (17). As this
process was demonstrated at low concentrations of IFN-γ, it may occur prior to the
disruption of tight junctions (17). Further studies will be necessary to investigate the
cellular changes that take place in order for IFN-γ to allow E. coli C25 to gain access to
epithelial monolayers, such as cellular signaling processes and IFN-γ-induced phenotypic
changes in intestinal cells (17).
2. The Effects of Enteroaggregative Escherichia coli (EAEC) vs. Commensal
Escherichia coli on Tight Junction Protein Localization
Enteroaggregative Escherichia coli (EAEC), one of the most common bacterial
pathogens occurring in patients with diarrhea, adheres to the intestinal mucosa where it
releases enterotoxins (18). The adherence of EAEC to the intestines is mediated by the
aggregative adherence fimbriae (AAF), which are related to the adhesions of some
enteropathogenic E. coli (18). A particular strain of EAEC, strain 042, exhibits the
AAF/II variant, which has been implicated in the delocalization of tight junction proteins
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and loss of epithelial integrity during infection (18).
Strauman at al. assessed the effects of EAEC strain 042 on intestinal epithelial
integrity in comparison to a commensal strain of E. coli (18). The results of the study
demonstrated AAF/II as a necessity for barrier dysfunction during EAEC infection (18).
The authors also compared the effects of EAEC on tight junction protein structure and
localization in vitro compared to commensal E. coli strain HS or 042aafA (18).
First, polarized T84 intestinal epithelial cell monolayers were infected with EAEC
strain 042 for 3 hours and TER was measured (18). After the infection period, the
monolayers were washed and TER was measured at different intervals for 21 hours (18).
At the end of the 3 hour infection period, there was no difference found in TER
between strain 042-infected and uninfected monolayers (18). However, during the hours
after the 3 hour infection period, the TER decreased significantly in the strain 042infected monolayers compared to uninfected monolayers and those infected with
commensal E. coli strain HS (18).
Next, in order to investigate barrier function directly, Strauman et al. assessed
monolayer permeability to FITC-conjugated dextran and FITC-conjugated BSA (18).
The ability of these molecules to move across the paracellular space was determined by
fluorescence in the basolateral compartment (18). After infection with strain 042,
augmented translocation of FITC-dextran and FITC-BSA was observed into the
basolateral compartment (18). Strain 042 infection did not enhance FITC-BSA flux;
therefore the authors concluded AAF/II was required to increase barrier
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permeability (18).
Strauman et al. then ruled out the possibility that EAEC affected TER through a
cell death mechanism by using the fluorescent Live/Dead viability/cytotoxicity kit assay
(18). The assay was used to quantitate the number of nonviable cells versus viable cells
in 042-infected T84 monolayers, where the live cells appear green and the nonviable cells
appear red (18). The cells were infected for 3 hours, and the assay was performed 21
hours later (18). No significant difference was found in the number of dead cells in
monolayers infected with 042 compared to uninfected and commensal strain HS
monolayers (18). Therefore, an EAEC 042 induced decrease in TER is not the result of
cell death (18).
Strauman et al. then investigated the effects of EAEC on the tight junction
proteins occludin, ZO-1, and claudin-1 (18). Strauman et al. hypothesized that the EAEC
induced increase in paracellular permeability was associated with the redistribution of
tight junction proteins (18). In uninfected T84 monolayers and T84 monolayers infected
with commensal E. coli strain HS, peripheral colocalization of occludin and ZO-1
occurred (18). However, in monolayers infected with strain 042, jagged intercellular
junctions and dissociation of occludin and ZO-1 within the tight junctions were observed
(Figure 9).
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Figure 9. Irregular morphology of T84 membranes and occludin delocalization following
infection with EAEC strain 042 and JM221. HS is a commensal E. coli strain. Occludin
(green) and ZO-1 (red). Adapted from Strauman et al. 2010.

In terms of cellular morphology, large, elongated cells in strain 042 infected
monolayers were seen, compared to that observed in uninfected and commensal strain HS
infected monolayers. In fact, some cells within the strain 042 monolayers even contained
more than one nucleus, as evident with DAPI staining, which may suggest synctium
formation (Figure 10). Claudin-1 was also dissociated from the tight junctions in strain
042 infected monolayers; whereas no dissociation of claudin-1 was observed in
uninfected and commensal strain HS infected controls (18).
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Figure 10. EAEC 042 infection results in the formation of large multinucleate cells.
Occludin (green), ZO-1 (red), and nuclei (DAPI). Adapted from Strauman et al. 2010.
In conclusion, Strauman et al. reported a loss of barrier function induced by
EAEC infection of T84 polarized monolayers (18). In relation to the previously
discussed studies, these experiments involved the comparison of a pathogenic strain of E.
coli to a nonpathogenic commensal strain of E. coli. Strauman et al showed a minimal
effect on tight junction proteins caused by commensal E. coli in comparison to EAEC
(18).
3. Interkingdom Signaling Between Commensal Bacteria and Host Cells
Recently an important discovery was made involving interkingdom signaling
between commensal bacteria and host cells in the human GI tract (19). A specific
bacterial signal, indole, is recognized as beneficial by intestinal epithelial cells (19). The
human GI tract is home to approximately

nonpathogenic commensal bacteria that

secrete various signaling molecules involved in the regulation of homeostasis and
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infections (19). Previous studies have focused on the recognition of human signals by
bacteria; however, Bansal et al. investigated the recognition of bacterial signals by human
epithelial cells (19).
The bacterial signal indole is produced in E. coli via tryptophanase; however, its
physiological role is poorly understood (19). It is likely that intestinal epithelial cells are
exposed to indole at high concentrations, as E. coli produce up to 600 uM of indole in
suspension cultures and the same concentration was detected in human feces (19). As
Bansal et al. hypothesized indole was beneficial to intestinal epithelial cells, changes in
gene expression were assessed with the human enterocyte cell line HCT-8 after exposure
to indole (19). Bansal et al. also assessed phenotypic measurements of TER, nuclear
factor kappa-B (NF-kB) activation, and IL-8 and IL-10 secretion (19)
The human colon cancer cell line HCT-8 was chosen because it is a polarizable
cell line used for investigating mechanisms of host-cell response to pathogens and
inflammation (19). HCT-8 cells were exposed to 1 mM indole or solvent for 4 hours or
24 hours (19). Next, RNA isolation and microarrays were performed to identify
statistically significant changes in gene expression (19).
Measurement of NF-κB activation was obtained with HCT-8 cells transduced
with a NF-κB-GFP reporter lentivirus (in order for the cell line to express NF-κB) and
then exposed to indole or indole-like molecules for a period of 4 hours (19). Then
40ng/mL tumor necrosis factor-alpha (TNF-α) was added, and image analysis was
performed with fluorescence microscopy (19). Flow cytometry and intracellular cytokine
staining were used to assess IL-10 expression in HCT-8 cells using phycoerythrin27

conjugated anti-human IL-10 antibody (19). IL-8 expression was determined with
ELISA (19)
Intestinal epithelial cell gene expression was determined with wholetranscriptome profiling (19). Exposure of cells to indole for 4 hours showed differential
expression of 523 genes (476 genes induced and 47 repressed) (19). Indole induced
specific genes associated with epithelial cell structure and function, including genes
responsible for tight junction organization (19). Seven claudin genes were induced after
24 hour exposure to indole, which may indicate an increase in paracellular resistance
(19). This observation is further supported by a decrease in pore-forming claudin-2
(cldn2) expression (19).
Several other important proteins were induced by indole; tight junction proteins
TJP1, TJP3, and TJP4, which are downstream of claudin-mediated tight junction
regulation (19). Indole induced cytoskeleton gene expression as well as a coordinated
induction of several cytoskeleton gene families, including actinin and cingulin (19). In
addition, several genes responsible for mucin production were induced by indole (19).
This is important because an increase in mucin production may weaken pathogen
colonization (19).
Next, in order to assess the effect of indole on tight junction function and cell
permeability, the TER of HCT-8 epithelial cells was measured after 4 hours and 24 hours
exposure to indole (19). The results showed an indole-induced increase in TER within 4
hours and a 1.6 fold increase after 24 hours (19). Also, when HCT-8 cells were
pretreated with 1mM indole for 24 hours, there was a decrease in EHEC colonization,
28

further supporting an indole-induced resistance to pathogen colonization (19). Overall,
the results of the gene expression analysis support the idea that indole improves epithelial
barrier function and may induce resistance to pathogens within the intestinal epithelium
(19).
Bansal et al. also investigated the role of indole in attenuating NF-kB activation
and the promotion of other epithelial barrier properties such as TER (19). First, the
effects of 5 indole-like molecules, H-indole-2,3-dione (isatin), 7-hydroxyindole (7-HI), 5hydroxyindole (5-HI), 2-hydroxyindole (2-HI), and indole-3-acetic acid (I3AA), were
determined compared to indole (19). Only 5-HI significantly attenuated NF-kB activity
similar to indole (19). Isatin actually increased NF-kB activity (19). Only 7-HI
demonstrated an increase in TER comparable to indole (19). Overall, the results showed
indole-like molecules were not capable of altering both NF-kB activity and TER
simultaneously, as indole could (19).
As there is little evidence for recognition of bacterial signals by host cells, Bansal
et al. provided insight into interkingdom communication and its role in pathogenesis (19).
The bacterial signal indole is recognized by intestinal epithelial cells and is beneficial in
terms of improving barrier function and resisting pathogen colonization (19). Indole is
produced by several commensal bacteria within the GI tract, including E. coli, which may
indicate the beneficial effects of commensal bacteria are mediated through indole
signaling (19).
The effects of indole on TER, inflammation, and paracellular permeability on
intestinal epithelial cells are quite relevant to intestinal inflammatory diseases, such as
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Crohn’s disease (19). Bansal et al. proposed indole as a novel and safe treatment for such
intestinal diseases, as it is naturally present in the GI tract (19). In conclusion, Bansal et
al. showed interkingdom signaling between intestinal epithelial cells and commensal
bacteria may be beneficial for epithelial integrity (19).

Table 1. A summary of the effects of commensal Escherichia coli on tight junction
permeability.
IV. THE EFFECTS OF ENTEROPATHOGENIC ESCHERICHIA COLI ON
TIGHT JUNCTION PERMEABILITY
1. The effects of Enteropathogenic Escherichia coli (EPEC) on Occludin and ZO-1
Redistribution
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Enteropathogenic Escherichia coli (EPEC) is a diarrheal disease responsible for
the deaths of several hundred thousand children each year (20). The characteristic
attaching/effacing (A/E) lesion is formed when EPEC colonizes the intestinal epithelial
surface (20). The intimate attachment of the bacteria to the epithelial cell membrane is
believed to play a crucial role in EPEC pathogenicity (20). The pathogenic mechanism
utilized by EPEC consists of effector virulence proteins injected into host cells via the
type three secretion system (TTSS), which is encoded by a pathogenicity island known as
the locus of enterocyte effacement (LEE) (20).
The EPEC secreted effector protein F (EspF) is necessary for disruption of tight
junction barrier function in vitro (20). Studies using epithelial cell lines in tissue culture
have demonstrated EPEC infection leads to a decrease in TER or polarized epithelial
monolayers as well as a disruption of tight junction barrier function through
redistribution, dephosphorylation, and dissociation of tight junction proteins (20). Zhang
et al. investigated the effects of EPEC infection on tight junction barrier function in vivo
(20).
Zhang et al. used 4 to 6-week old male C57BL/6J mice as an in vivo model of
EPEC infection (20). The mice were infected with wild-type (WT) EPEC and a mutant
EPEC strain that was missing the EspF gene (ΔespF) by oral gavage of 2 x

EPEC

suspended in 200 ul of sterile PBS (20). The control element consisted of 200 ul of
sterile PBS (20). For the histological analysis, colon tissues of control and EPEC
infected mice were excised, washed with PBS, and fixed in formalin (20). Tissue
sections were cut with a microtome and stained with hemetoxylin and eosin (H&E) (20).
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Sections of colon were also excised for transmission electron microscopy analysis (20).
The tissue sections were fixed in gluteraldehyde, post fixed in OsO4, dehydrated through
graded alcohols, infiltrated through Epon 812, and then embedded in resin (20). Next,
sections were cut and stained with uranyl acetate and lead citrate and observed with a
transmission electron microscope (20).
Tissues used in immunofluorescence analysis were incubated with monoclonal
antibodies against occludin or ZO-1, washed, then incubated with secondary antibodies
(20). The images were examined with a laser confocal scanning microscope (20).
Mucosal permeability was also assessed using a tracer experiment (20). After the
mice were sacrificed, biotin was injected into the colon (20). The portion of the colon in
contact with the biotin solution was cut, preserved, washed, sectioned, and then examined
using a confocal scanning microscope (20).
Upon microscopic examination of the dissected colons from the mice, the results
indicated well formed stools in the colons of the control mice and engorged colons with
diffuse stools in the EPEC infected mice (20). The EPEC infected mice also showed
mild intestinal inflammation of the ileum 5 days post infection (20). Pathological
changes in the colonic mucosa of EPEC infected mice were more severe on day five
compared to control mice (20).
Next, Zhang et al. investigated changes in tight junction ultrastructure in EPEC
infected mice (20). In the control mice, tight junction morphology appeared typical with
intact membrane fusions and desmosomes (Figure 11). However, in EPEC infected mice,
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tight junctions were discontinuous with decreased membrane fusions (Figure 11). The
mice infected with the mutant strain (ΔespF) of EPEC displayed similar tight junction
morphology compared to control mice 1 day post infection (Figure 11). At 5 days post
infection, the mice infected with the mutant EPEC strain displayed altered tight junction
morphology, as well as a disappeared desmosome (Figure 11).

Figure 11. Alteration of tight junction morphology after 5 days infection with EPEC.
Intact tight junction structure and normal desmosomes in control mice (A) WT EPEC
infected mice, abnormal tight junctions and desmosomes (B-D). Mice infected with
ΔespF for 1, 3, and 5 days (E-G). Arrows: tight junction, arrow heads: desmosomes.
Adapted from Zhang et al. 2010.

Zhang et al. then examined whether tight junction barrier function was altered
during EPEC infection with the tracer experiment (20). In the control mice, the biotin
fluorescent signals were restricted to the lumen of the colon (20). In EPEC infected
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mice, the biotin permeated the epithelium into the lamina propria and was distributed
diffusely in the colon tissue (20). In the mutant EPEC infected mice, the tight junctions
appeared to be intact up until 5 days post infection, when the biotin tracer penetrated into
the tissue (20).
Next, the localization of the tight junction proteins occludin and ZO-1 during
EPEC infection were assessed with immunofluorescence experiments (Figure 12).
During EPEC infection, occludin was redistributed to the apical region of epithelial cells,

Figure 12. The redistribution of occludin in EPEC infected mice. Arrows: localization of
tight junction proteins at tight junctions, arrowheads: lack of tight junction protein
staining. Adapted from Zhang et al. 2010.
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compared to control mice (20). In mice infected with the mutant strain ΔespF, occludin
distribution was the same as control mice up until 5 days post infection, where it was
present in the tight junction and cytoplasm (20).
The distribution of ZO-1 was also altered during EPEC infection (Figure 13).
ZO-1 was localized diffusely within cells infected with EPEC (20). In control mice, ZO1 remained in the epithelial cell membrane (20). A change in ZO-1 distribution was not

Figure 13. The redistribution of ZO-1 in EPEC infected mice. Arrows: localization of
tight junction proteins at tight junctions, arrowheads: lack of tight junction protein
staining. Adapted from Zhang et al. 2010.
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observed in mice infected with the mutant strain of EPEC until 5 days post infection (20).
Overall the results of the study demonstrated an EPEC-induced disruption of tight
junctions caused by an increase in permeability and alteration of tight junction structure
(20). The disruption in tight junction function was evident by the redistribution of
occludin and ZO-1 in the colon tissues (20). The study is of importance because very
little is understood about the in vivo effects of EPEC on tight junction permeability (20).
As EspF plays a major role in the pathogenesis of EPEC, Zhang et al. included a
mutant strain of EPEC (ΔespF) in the experiments (20). Mice infected with the mutant
strain of EPEC showed little change in intestinal barrier function at 1 day post infection,
suggesting EspF is necessary for altered barrier function during EPEC infection (20). In
conclusion, Zhang et al. shed light on the mechanism by which EPEC disrupts tight
junction barrier function in vivo, which included a redistribution of the tight junction
proteins occludin and ZO-1 (20).
During infection with EPEC, host cytoskeletal proteins are phosphorylated
beneath the formed lesions (21). The light chain of myosin (MLC) is the main protein
that is phosphorylated during EPEC infection and is involved in the regulation of tight
junction permeability (21). The tight junction protein occludin also requires
phosphorylation in order to remain associated with the membrane at the level of the tight
junction (21).
Phosphorylated occludin is also believed to play a major role in forming the tight
junction “seal” (21). Simonovic et al. investigated the effects of EPEC on the tight
junction protein occludin in comparison to non-pathogenic E. coli (21).
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Dephosphorylation of occludin may contribute to the pathogenicity of EPEC (21).
First, human T84 intestinal epithelial cells were infected with EPEC for 1, 3, or 5
hours before immunostaining with occludin (21). After only one hour post infection,
occludin was still confined to the membrane; however, distribution took on a beaded
appearance (Figure 14). After 3 hours of infection occludin became redistributed to an
intracellular compartment and showed a decreased association with tight junctions
compared to uninfected monolayers (Figure 14).

Figure 14. The redistribution of occludin in EPEC infected cells. (A). Uninfected control
cells demonstrate localization of occludin. (B). Occludin distribution takes on a beaded
appearance after 1 hour of infection with EPEC. (C). Dissociation of occludin from the
membrane after 3 hours of EPEC infection. (D and E). Actin distribution within control
(D) and EPEC infected cells (E) is unchanged. Adapted from Simonovic et al. 2000.
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When separated by SDS-PAGE and identified by immunoblotting, occludin
appears as two distinct bands, the higher molecular weight band being
hyperphosphorylated occludin (21). Hyperphosphorylated occludin localizes to the tight
junction (21). The lower molecular weight band, or non-phosphorylated occludin, is
located within a cytoplasmic compartment and/or the basolateral membrane (21).
Simonovic et al. then investigated the effects of EPEC on occludin
phosphorylation in T84 cells compared to uninfected controls (Figure 15). In the
uninfected control cells, occludin mostly resolved within the high molecular weight band,
which indicates hyperphosphorylation (Figure 15). In EPEC infected cells, the results
showed a reciprocal relationship in accordance with time (Figure 15). Therefore, it can
be inferred that EPEC infection in epithelial cells leads to dephosphorylation of occludin,
thereby disassociating the protein from the tight junction (21).

Figure 15. EPEC infection of intestinal T84 cells induces dephosphorylation of occludin.
The first lane, U, represents uninfected control cells. The following lanes represent 30
min, 1 hour, and 3 hours post infection with EPEC. The upper band represents
hyperphosphorylated occludin and the lower band represents unphosphorylated occludin
(19). Adapted from Simonovic et al. 2000.
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Next, Simonovic et al investigated whether the serine/threonine phosphatase
inhibitor, calyculin A, would prevent the redistribution of occludin and decrease in TER
caused by EPEC infection (21). The inhibitor was chosen because occludin is
phosphorylated on both serine and threonine residues (21).
The T84 monolayers were infected with EPEC in the absence or presence of
calyculin A (3 and 4nM) and examined with immunofluorescence microscopy (21).
Calyculin A (at both concentrations) fully prevented the dissociation of occludin from the
tight junctions in the EPEC infected monolayers (21).
Expression of certain genes within the locus of enterocyte effacement (LEE) plays
a role in host cell physiology during EPEC infection (21). In fact, when non-pathogenic
E. coli K-12 is transformed with LEE of EPEC, E. coli K-12 is able to form A/E lesions
and decrease TER (21). Therefore, Simonovic et al. investigated the effects of nonpathogenic E. coli K-12 and a LEE-transformed K-12 on occludin distribution (21).
E. coli K-12 had no effect on occludin localization (Figure 16).

Figure 16. Occludin redistribution in T84 cells infected with non-pathogenic E. coli K-12
(A) and E. coli K-12 transformed with LEE (B) for 3 hours. Adapted from Simonovic et
al. 2000.
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However, the LEE-transformed K-12 displayed occludin localization identical to that of
wild-type EPEC, and a decrease in TER very similar to wild-type EPEC (21).
Overall, EPEC induced phosphorylation of the tight junction protein occludin,
which leads to the dissociation of occludin from the tight junction (21). These effects
were also prevented with the serine-threonine phosphatase inhibitor calyculin A (21).
Interestingly, when non-pathogenic E. coli K-12 is transformed with the LEE of EPEC, it
takes on the phenotype of wild-type EPEC (21).
Simonovic et al. discussed how the integrity of the tight junction is not dependent
upon a single protein, such as occludin (21). Therefore, future studies should focus on
the effects of EPEC on each tight junction protein involved in barrier function, such as
the claudin family and ZO-1 (21). Future experiments should examine whether the EPEC
induced dephosphorylation of occludin also induces other effects on claudin or ZO-1 in
order to fully disrupt barrier function.
As discussed previously, the EPEC effector protein EspF is believed to play a
crucial role in decreasing TER and altering tight junction structure in the intestinal
epithelium (22). However, the mechanism by which EspF disrupts barrier function in
vitro has not been fully explained (22). As small animal models for studying EPEC in
vivo are limited, Shifflett et al. set out to establish the C57BL/6J mouse as a suitable
model for EPEC infection in order to investigate the effects of EPEC on tight junctions
(22). Shifflett et al. also included an examination of the role of EspF in the mouse model
(22).
The experimental methods included male 6 week old C57BL/6J mice that were
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gavaged with 200 uL of sterile PBS as a control or 2 x

EPEC suspended in 200 uL

sterile PBS (22). The mice were killed by asphyxiation at 1 or 5 days post infection and
intestinal tissue was resected (22). Ileal and colonic tissue were mounted in Ussing
chambers to measure TER (22). Ileal and colonic tissues were also snap-frozen and
analyzed with immunofluorescent microscopy (22).
Attachment assays were performed in order to assess the level of attachment of
wild-type (WT) EPEC and mutant EPEC strains to the ileum and colon of the mice (22).
Ileal and colonic tissues were also snap frozen in liquid nitrogen immediately after
euthanasia for protein analysis with gel electrophoresis and western blotting (22). RNA
was extracted from ileal and colonic tissues and analyzed with quantitative real-time PCR
(RT-PCR) (22).
The results indicated EPEC colonization of the ileum occurred 1 day post
infection and continued for 5 days post infection (22). Furthermore, WT EPEC and
ΔespF showed the same level of colonization after 1 and 5 days post infection (22). WT
EPEC significantly reduced the barrier function of the ileum and the colon, as determined
by TER measurement (22). However, at 1 day post infection the ΔespF strain showed no
effect on the barrier function of the ileum and colon (22).
Next, Schifflett et al. examined whether the WT EPEC-induced change in barrier
function was a result of a change in tight junction structure (22). As expected, occludin
was found at the tight junction and dissociated to the apical and basal cytoplasm of ileal
and colonic epithelial cells of WT EPEC infected mice at day 1 (22). Occludin remained
localized at the tight junctions in the ileum and colon of the uninfected control mice as
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well as ΔespF infected mice at day 1 (22).
The tight junction protein ZO-1 was localized with the perijunctional actomyosin
ring in control uninfected mice and ΔespF infected mice (22). Interestingly, ZO-1 was
also localized to the tight junction in EPEC-infected mice (22). Therefore, the
redistribution of tight junction proteins during EPEC infection may not be a global effect
(22).
After 5 days post infection, the effect of the WT EPEC infected mice on barrier
function was similar to that of 1 day post infection (22). In ΔespF infected mice the
barrier function of the ileum and colon was at the same level induced by WT EPEC at 5
days post infection (22). Also, in ΔespF infected mice, the distribution of occludin and
ZO-1 in ileal and colonic epithelium were indistinguishable from that of WT EPEC
infected mice at 5 days post infection (22). Therefore, barrier function in ΔespF infected
mice is preserved at 1 day post infection and disrupted at 5 days post infection (22).
Overall, Schifflett et al. demonstrated EPEC infection disrupts intestinal barrier
function in vivo (22). Specifically, EPEC induces a redistribution of the tight junction
protein occludin (22). The alterations in barrier function are mediated by EspF during
early infection (1 day post infection) but not at later time points (5 days post infection)
(22).
It is interesting to note however, the results obtained by Schifflett et al. are
different from the previously discussed study by Zhang et al. (20, 22). Zhang et al.
demonstrated changes in the distribution of the tight junction protein ZO-1 in WT EPEC
infected mice as well as ΔespF infected mice (20). The changes were also time
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dependent, as they occurred 5 days post infection (20). Schifflett et al. reported no
change in the distribution of ZO-1; only changes in the distribution of occludin were
observed (22).
In both studies, similar mice models were used, as well as similar experimental
methods (20, 22). Future studies should aim to rectify the contrasting results, in order to
verify whether the tight junction protein ZO-1 is actually redistributed during infection
with EPEC by assessing ZO-1 localization and expression level at 1, 3, and 5 days post
infection with EPEC. This information is important as ZO-1 is crucial to tight junction
integrity and barrier function.
2. Type Three Secretion System Effector Proteins
In addition to EspF, there are other effector molecules delivered into the host cell
that alter epithelial paracellular permeability during EPEC infection, such as EspG and
EspG2 (21). Matsuzawa et al. examined the effects of the type III effectors EspG and
EspG2 on epithelial paracellular permeability and tight junction architecture in MDCK
monolayer cells (23).
Matsuzawa et al. first confirmed EspG2 was secreted via the TTSS by preparing
secreted proteins from bacterial culture supernatant, followed by a Western blot analysis
using anti-EspG2 antibodies (23). Next, Matsuzawa et al. confirmed EPEC injects
EspG2 into the host cell via the TTSS using a fluorescence-based reporter system (23).
Plasmids encoding TEM-1 fused proteins were introduced into EPEC, thereby
demonstrating the secretion of TEM-1-fused proteins (23).
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The EPEC secreted effector proteins EspG and EspG2, which have been shown to
disrupt the host cell microtubule network, can activate the GEF-H1-mediated RhoA-Rho
Kinase (ROCK) signaling pathway in HeLa cells (23). This is important because the Rho
family of GTPases have been implicated in the maintenance of tight junction assembly
and function via the actin cytoskeleton (23). Matsuzawa et al. used an infection assay
with EPEC-infected polarized MDCK cells to determine whether RhoA (a central
regulator of the actin cytoskeleton) was activated (23). RhoA levels were higher (a 1.7
fold increase) in WT EPEC infected cells as opposed to cells infected with the
espG/espG2 double knockout mutant (23).
Next, polarized MDCK cells infected with WT EPEC or the espG/espG2 double
knockout mutant were assessed for induction of tight junction disruption (23). A
decrease in TER was observed in WT EPEC infected monolayers as well as in the
espG/espG2 mutant infected monolayers (23). Furthermore, ZO-1 disruption was
observed in both the WT EPEC infected monolayers and the espG/espG2 knockout
infected monolayers (23).
Neither EspG or EspG2 induced the distribution of ZO-1 and claudin-1 polarized
MDCK cells (23). Next, paracellular permeability was measured in MDCK monolayers
expressing EspG or EspG2, in order to determine the effector proteins’ involvement in
tight junction barrier function (23). In cells expressing EspG or EspG2 there was a fivefold upregulation of the paracellular permeability to 4-kDa FITC-dextran (23). However,
the upregulation was not observed in 500-kDa FITC-dextran (23).
Matsuzawa et al. provided evidence for the secretion and translocation of EspG2
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into host cells via the TTSS during EPEC infection (23). The activation of RhoA is also
dependent upon EspG and EspG2 activity in MDCK cells during EPEC infection (23).
However, although EspG and EspG2 were found to alter paracellular permeability, the
effectors were not involved in tight junction disruption (23).
As there are many known effectors secreted into host cells via the TTSS during
EPEC infection, it will be important to investigate the synergistic effects that take place
during pathogenisis (23). The previously discussed effector EspF is still not fully
understood; therefore it will also be important to verify the results of the study by
Matsuzawa et al. in order to avoid confusion regarding the effects of EspG and EspG2.
Future studies should also assess how EspG, EspG2, and EspF work in concert
with one another and if EspG and EspG2 truly have no affect on tight junction function,
by evaluating which signaling pathways are activated during effector protein secretion.
The experiments should also include an analysis of all crucial tight junction proteins such
as ZO-1, occludin, and claudin.
3. The Redistribution of Claudin and Occludin in Tight Junction Membrane
Microdomains
Recently, Zhang et al. investigated the effects of EPEC on tight junction
permeability in vivo (24). Zhang et al. used an A/E mouse infection model to
demonstrate the disruption of specific tight junction proteins, occludin and claudin-1,
during EPEC pathogenesis (24).
Four- to 6-week-old male C57BL/6J mice were orally infected with WT EPEC
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2348/69 (2 x

) EPEC suspended in 200 uL sterile PBS) for 1, 3, or 5 days before

they were sacrificed (24). A subset of mice received only sterile PBS as a control (24).
Next, the colon tissues of the mice were fixed in formalin, stained with H&E, sectioned,
and observed with light microscopy (24).
Zhang et al. also isolated tight junction microdomains using sucrose density
gradient centrifugation and homogenizing tissue samples in lysis buffer and protease
inhibitor mixture solution, then examined by immunoblotting (24). In order to assess
intestinal mucosal permeability, an EZ-link Sulfo-NHS-Biotin tracer was used to
visualize penetration of the epithelia (24). The results, as observed with H&E staining,
indicated the colon from the control mice was intact and well-organized (24). In the
EPEC infected mice, the number of epithelial cells decreased and there was an irregular
epithelial surface, mucosal hyperplasia, and infiltration of inflammatory cells (24).
Next, Zhang et al. investigated tight junction protein expression within membrane
microdomains of tight junctions (24). The experiment was based on previous reports that
the spacial organization of tight junctions is mediated by lipid raft-like compartments (24,
25). Detergent-resistant tight junction membrane microdomains were isolated with
detergent extraction and sucrose density gradient centrifugation (24). Proteins were
analyzed with Western blotting (24).
EPEC infection induced the redistribution of occludin and claudin-1 out of tight
junction membrane microdomains (Figure 17). In the control mice, 19.6% occludin
(percentages are measured as a fraction of the density gradient) was observed in tight
junction membrane microdomains (24). However, the results showed occludin was
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displaced from the low-density fractions to the bottom of the gradient (Figure 17). The
tight junction protein claudin-1 was also redistributed in a similar manner (Figure 17).

Figure 17. A representation of Western Blott analysis of the distribution of occludin (d)
and claudin-1 (f) in tight junction membrane microdomains. Asterisks indicate a
significant difference compared to control (*P<0.05, **P<0.01, ***P<0.001). Adapted
from Zhang et al. 2012.
The next experiment involved the use of molecular biotin tracer to assess the
integrity of the epithelial barrier (24). Claudin-3 and -5 were double-labeled with the
biotin tracer (24). In the control model, biotin was restricted to the luminal boundary of
the colon epithelium (24). However, once infected with EPEC, the biotin tracer
permeated the epithelium and entered into the lamina propria (24). The results showed
the tracer entered into the epithelium through areas of altered claudin location (24).
Overall, tight junctions were functionally altered by EPEC infection in vivo (24).
The changes in tight junction function were associated with a redistribution of occludin
and claudin in tight junction membrane microdomains (24). The results are of clinical
47

relevance as claudin expression was altered in patients with Crohn’s disease (24).
Zhang et al. also expanded upon the previously discussed study, which included
several of the same authors, by investigating the tight junction protein claudin (20, 24).
Previously, Zhang et al. used a biotin tracer and immunofluorescent microscopy to assess
paracellular permeability and the redistribution of ZO-1 and occludin (20). The results
from both studies were similar, in that EPEC infection lead to the redistribution of tight
junction proteins in vivo, thereby providing further evidence for a loss of tight junction
function during EPEC infection (20, 24).

Table 2. A summary of the effects of enteropathogenic Escherichia coli on tight junction
permeability.
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V. DISCUSSION

The effects of pathogenic and commensal bacteria on host intestinal epithelial
cells are not fully understood. The intestinal epithelium has been described as a haven
for “cross talk” between the host and its prokaryotic inhabitants, where countless
signaling pathways lead to physiological transformations (3). One of the major ways by
which bacteria induce physiological changes in the intestinal epithelium is through
alteration of tight junctions.
As discussed here, infection with Enteropathogenic Escherichia coli (EPEC) is
widely associated with the disruption of tight junction proteins (20, 21, 22, 23, and 24).
Both in vitro and in vivo studies have demonstrated EPEC infection induces redistribution
of the tight junction proteins occludin, claudin-1, and ZO-1 (20, 22, 23, and 24). It is not
yet determined whether the effector proteins secreted by EPEC into the host cell are
involved in the alteration of tight junction function. Matsuzawa et al. showed the effector
proteins EspG and EspG2 do not play a role in tight junction disruption (23).
However, the EPEC effector protein EspF is widely attributed to alterations in
tight junction barrier function (18). A deletion of EspF significantly weakened the effect
of EPEC on TER as well as induced alterations in tight junction protein distribution 10).
EspF is also required for tight junction disruption during infection with other pathogenic
bacteria, such as Enterohemorrhagic Escherichia coli and Citrobacter rodentium 10). As
these pathogens also utilize the production of A/E lesions, this may suggest an
evolutionary conserved phenotype (10)
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Another effector protein secreted by the TTSS during EPEC infection, NleA, has
been implicated in altering epithelial barrier function (26). For example, Thanabalasuriar
et al. showed polarized epithelial cells infected with EPEC displayed a NleA-induced
dislocation of ZO-1 and occludin, which was independent of NleA’s PDZ-binding
domain (26).
If EPEC are a non-invasive bacteria and utilize a secretion system for virulence,
why would EPEC want to disrupt tight junction barrier function? The intestinal
epithelium must maintain a tight barrier between cells in order to regulate the passage of
specific nutrients between the digestive tract and the submucosa (10). The
transmembrane proteins of tight junctions prevent the unregulated movement of the
nutrients between said compartments (10). Therefore, it would be beneficial for EPEC to
alter tight junctions during infection, in order to have access to nutrients and continue
colonization within the host.
Mucus production in the gut also plays an important role in nutrient availability
for microorganisms (27). The secretion of mucus by goblet cells is a defense mechanism
against pathogens entering the epithelium (27). Through peristaltic movement, mucins
are able to entrap and remove microbes (27). However, mucin also provides a direct
source of carbohydrates and peptides to bacteria, enabling their colonization within the
host (27).
Recently, commensal bacteria were implicated in the pathogenesis of intestinal
diseases, such as IBD, and commensal E. coli may alter tight junction barrier function
(6). As discussed here, various other factors may contribute to the effects of commensal
50

E. coli on tight junction permeability, such as metabolic stress (15, 16). According to
Nazli et al., epithelial cells under metabolic stress (represented by the chemical stressor
DNP) may perceive commensal bacteria as a threat (15).
However, there were several limitations within the studies involving the use of
DNP as a chemical stressor. The use of DNP may not accurately mimic physiological
conditions during times of stress within the host. Furthermore, the optimal concentration
of DNP necessary to “stress” the epithelium was not discussed by Nazli et al. (15). A
future study should involve the identification of a physiologically relevant stressor of the
host epithelium and determine an appropriate concentration to use in order for the
epithelium to perceive commensal bacteria as a threat.
As the effects of commensal E. coli on tight junction permeability are not as clear
as that of EPEC, future studies should focus on elucidating the potential risks of
commensal bacteria on epithelial integrity. In order to determine whether commensal E.
coli are actually posing as a threat during metabolic stress within the host, the cell
signaling pathways induced by commensal E. coli must be assessed. Is there a particular
effector protein secreted by commensal E. coli, similar to that of EPEC, that causes a
phenotypic switch during times of stress?
First, a group of human colonic T84 epithelial cells should be treated with a nonpathogenic commensal E. coli strain and a chemical stressor. In order to determine which
signaling pathways are activated by non-pathogenic commensal E. coli, a kinase activity
assay will be performed. This would determine which downstream effectors are
responsible for the altered barrier function induced by commensal E. coli during
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metabolic stress.
There is evidence that some commensal bacteria utilize a secretion system, similar
to some enteropathogenic bacteria (28). For example, genomic analysis of microbiota in
the gut has demonstrated the existence of type III secretion systems in bacterial species
that were known to be commensal (28). Whether these secretion systems are necessary
for commensal bacteria to become pathogenic is not known (28).
In conclusion, the effects of commensal E. coli and EPEC on tight junction
permeability range from negligible to severe, indicating the need for more extensive
research in the field. As both commensal E. coli and EPEC have been implicated in
chronic intestinal diseases, it will also be important to determine how alterations in
epithelial barrier function can be remedied for clinical applications.
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